1st Quarter - Report

GOLDBUG STRATEGIES LLC for GENOMIC HEALTH INC.

Firm
Client
Income
$110,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 14, 2011 $110,000 Replaced
1st Quarter - Report (this page) Apr 14, 2011 $110,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests.

LobbyistCovered position, as disclosed
SHEILA D WALCOFF Committee, US House Of Representatives

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Health Issues HCR

FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests.

LobbyistCovered position, as disclosed
SHEILA D WALCOFF Committee, US House Of Representatives

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests.

LobbyistCovered position, as disclosed
SHEILA D WALCOFF Committee, US House Of Representatives

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.